Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > News & Updates > Regulatory Updates > General

General

DRAP issued guidance on Remote Virtual Inspection (RVI) for GMP Assessment of overseas manufacturing facilities for registration of finished Pharmaceutical Drugs and Biologicals

Ijaz Mustafa Drugs, General September 27, 2022September 28, 2022

Virtual_Inspection_LetterDownload

Circular: Mecobalamin Manufacturing and Testing

Ijaz Mustafa Drugs, General April 5, 2022April 5, 2022
Mecobalamin-Manufacturing-TestingDownload

Circular: Cefixime Capsule 200mg & 400mg Specifications.

Ijaz Mustafa Drugs, General April 5, 2022April 5, 2022
Cefixime-Capsule-SpecificationsDownload

Online Training of Licensing Module of PIRIMS software will be held by the MIS Division on 01 Mar,2022 2:00 PM on DRAP Facebook page

Ijaz Mustafa General February 28, 2022February 28, 2022

CEO, DRAP will hold Khuli E-Kachehri on 28th February, 2022

Ijaz Mustafa Events, General February 22, 2022February 24, 2022
Khuli-Kachehri Download

Attention: – Manufacturers of Pharmaceuticals and Biologicals Drug

Ijaz Mustafa Drugs, General February 14, 2022February 24, 2022
PIRIMS-v3-3Download

Draft Guidelines On Good Pharmacovigilance Practices For Registration Holders for view Comments to be Submitted to National PV Center DRAP till 15th January, 2022

Murtaza Awan General December 29, 2021January 6, 2022Pharmacy Services

Guidelines On Good Pharmacovigilance Practices For Registration Holders

PDF File Download

User Guide For Online Import / Export Applications Software

Murtaza Awan Drugs, General December 28, 2021January 6, 2022QA & LT

User Guide For Online Import / Export Applications Software.

PDF FileDownload

Training: Implementation of online software for import export clearance

Yasir Mahmood General December 16, 2021December 27, 2021Other

Training announcement for software for import export clearance (therapeutic goods raw material).

PDF FileDownload

Holding Of Khuli E.Kachehri

Murtaza Awan General, News & Updates November 22, 2021December 29, 2021Other

As per directions of Prime Minister’s office for reaching out to public through Khuli E-Kacheri, CEO-DRAP has been pleased to schedule holding of 14th Khuli E-Kachehri through LIVE session on official Facebook page of DRAP (www.facebook.com/OfficialDRAP) on 24th November-202l (Wednesday) at 10:00 am to address public complaints relating to DRAP.

Khuli-Kachehri-14thDownload

  • ← Previous
  • Next →
  • Drugs
  • Medical Devices
  • Alternative Medicines
  • Controlled Substances
  • Licensing and Inspections
  • Clinical Trials
  • Pharmacovigilance
  • Advertisements
  • General

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem